PMID: 16515769Mar 7, 2006Paper

Idiopathic hypercalciuria

Current Rheumatology Reports
Scott E LiebmanDavid A Bushinsky

Abstract

Hypercalcuria is the most common metabolic disorder found in patients with nephrolithiasis. As the prevalence of kidney stones rises in industrialized nations, understanding the pathogenesis and treatment of hypercalciuria becomes increasingly important. Idiopathic hypercalciuria (IH), defined as an excess urine calcium excretion without an apparent underlying etiology, is the most frequent cause of hypercalciuria and will be the focus of this paper. Calcium homeostasis is tightly controlled and slight disturbances in transport at the level of the intestine, bone, and/or kidney can lead to excessive urine calcium excretion and promote stone formation. IH is a systemic disorder with dysregulation of calcium transport at a combination of these calcium regulatory sites. The goal of treatment is to prevent stone formation and relies on a combination of dietary and pharmaceutical interventions. Dietary management includes increasing fluid intake, salt restriction, animal protein restriction, and maintaining a normal calcium intake. Thiazide diuretics have proven effective in preventing calcium stone formation by reducing the urinary excretion of calcium. It is important to note that while decreasing urinary calcium excretion is impo...Continue Reading

References

Nov 1, 1988·The Journal of Clinical Investigation·D A Bushinsky, M J Favus
Jan 1, 1995·The American Journal of Medicine·F L LevyC Y Pak
Sep 1, 1994·Kidney International·J M SoucieH Austin
Jan 1, 1993·Kidney International·M KimD A Bushinsky
Dec 1, 1995·Kidney International·D A BushinskyF L Coe
Jul 1, 1996·The American Journal of Physiology·N S KriegerD A Bushinsky
Oct 10, 1996·The New England Journal of Medicine·S H PearceR V Thakker
May 1, 1997·Kidney International·S TsuruokaG J Schwartz
Jun 23, 1998·Lancet·C Y Pak
Jan 20, 1999·Kidney International·D A BushinskyN S Krieger
Jan 23, 1999·The Journal of Nutrition·F Bronner, D Pansu
Jun 26, 2001·Journal of the American Society of Nephrology : JASN·Joost G J HoenderopRené J M Bindels
Jan 11, 2002·The New England Journal of Medicine·Loris BorghiAlmerico Novarini
Feb 19, 2002·Kidney International·David A BushinskyFredric L Coe
Aug 9, 2002·American Journal of Physiology. Renal Physiology·Hiroki I Motoyama, Peter A Friedman
Jan 10, 2003·Journal of Cellular Biochemistry·Tatsuo SudaToshimasa Shinki
Mar 28, 2003·Journal of the American Society of Nephrology : JASN·Kevin K Frick, David A Bushinsky
Apr 5, 2003·Kidney International·Kiriaki K StamatelouGary C Curhan
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Richard R HoopesSteven J Scheinman
Oct 9, 2003·American Journal of Physiology. Renal Physiology·Jacob LemannL Lee Hamm
Jun 18, 2004·Cell Calcium·Jianming Ba, Peter A Friedman
Oct 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Murray J FavusFredric L Coe
Dec 25, 2004·Physiological Reviews·Joost G J HoenderopRené J M Bindels
Jan 14, 2005·Journal of the American Society of Nephrology : JASN·David A Bushinsky, John R Asplin
Feb 4, 2005·Journal of the American Society of Nephrology : JASN·Orson W Moe, Olivier Bonny
Mar 5, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Alexander J KarnauskasMurray J Favus
Mar 25, 2005·Journal of the American Society of Nephrology : JASN·Jim J YaoMurray J Favus
Oct 4, 2005·The Journal of Clinical Investigation·Fredric L CoeElaine Worcester

❮ Previous
Next ❯

Citations

Nov 28, 2012·Current Urology Reports·Jianghui Hou
Dec 17, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andrea GiustiGerolamo Bianchi
Aug 18, 2006·Current Opinion in Nephrology and Hypertension·Arjen R MensenkampRené J M Bindels
Jul 2, 2010·American Journal of Physiology. Renal Physiology·Yan LiuXue-Ru Wu
Feb 1, 2010·Therapeutic Advances in Musculoskeletal Disease·Gerolamo BianchiGiuseppe Girasole
Aug 6, 2008·BMC Musculoskeletal Disorders·Bianca DumitrescuPiet Geusens
May 25, 2012·AJR. American Journal of Roentgenology·Phillip M ChengVinay A Duddalwar
Sep 10, 2009·Human & Experimental Toxicology·Rita de Cássia Oliveira da Costa MattosMaria de Fátima Malizia Alves
Aug 8, 2014·Scientifica·Lars RejnmarkTanja Sikjaer
May 11, 2015·Urolithiasis·Francisco Rodolfo SpivacowPaula Rey
Aug 23, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Paul D Miller
Dec 19, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Anita RathodMurielle Bochud
Mar 13, 2021·Therapeutic Advances in Urology·Derry Minyao NgQi Ma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.